Hamid Khoja discloses 7.5% stake in FibroBiologics
Khoja, FibroBiologics’ chief scientific officer, disclosed a 7.5% stake via a Schedule 13D filed Sep. 17, 2026, tied to a Sept. 15, 2026 private placement of 298,508 shares with accompanying warrants.